Clair

by Clair Health  · Based in United States → — The First Continuous Hormone Monitor — Track Estrogen, Progesterone & More
Women's Health

$369 device + $9.99/month subscription
Regulatory Status Disclosed

Overview

Clair is an advanced AI-powered clinical decision support tool specifically designed to provide instant and accurate drug interaction analysis for healthcare professionals. Leveraging a robust knowledge base derived from authoritative sources such as the FDA, NIH, and established clinical guidelines, Clair helps physicians quickly identify potential adverse drug interactions across multiple medications.

The platform aims to enhance patient safety and streamline medication management workflows. By offering integration capabilities into existing EHR systems, Clair provides real-time insights at the point of care, reducing the risk of medication errors and improving prescribing confidence. Its intuitive interface presents complex interaction data in a clear, actionable format, allowing physicians to make informed decisions efficiently.

Clair supports comprehensive polypharmacy management, a critical need in modern healthcare. It goes beyond basic interaction checks by analyzing the cumulative effect of multiple drugs, providing guidance that considers the full medication regimen. This proactive approach helps prevent adverse events before they occur, ultimately leading to better patient outcomes and reduced healthcare costs associated with preventable drug-related complications.

Committed to data security and patient privacy, Clair is fully HIPAA-compliant, ensuring that all patient information is handled with the highest standards of confidentiality. While specific pricing details are typically provided upon request, the tool is designed for integration into various clinical settings, from individual practices to large health systems, offering a scalable solution for medication safety.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Instant drug interaction analysis
  • Trained on FDA, NIH, and clinical guidelines
  • Supports multiple drug regimens (polypharmacy)
  • Clear, actionable guidance
  • EHR integration capabilities
  • Enhances patient safety
  • Reduces medication errors

Use Cases

  • Prescribing new medications
  • Medication reconciliation
  • Managing polypharmacy patients
  • Preventing adverse drug events
  • Clinical decision support at point of care
  • Optimizing medication regimens

What Physicians Need to Know

Evidence Base
Clair's AI model is trained on an extensive database including over 200 million clinical studies, 147,000+ FDA inserts, 2 million drug interactions, and 100+ clinical guidelines. It employs intelligent sourcing to dynamically select the most relevant information, such as FDA drug package inserts for side effects or NIH clinical trial data for comparative efficacy. Every response provides an answer, an evidence summary, and direct links to original, legitimate references for verification.
Alert Fatigue Management
Clair focuses on delivering 'ultra-fast, concise and specific' answers to clinical questions, aiming to reduce the time clinicians spend searching through documentation. This approach may indirectly mitigate alert fatigue by streamlining information retrieval, though explicit features for managing alert volume or relevance are not described.
Drug Interaction Checking
Clair offers a dedicated Drug Interactions API designed to identify and prevent significant drug-drug interactions. Users can submit a list of up to 25 drugs per query and receive structured JSON output detailing interacting pairs, descriptions, recommendations with severity, and references. Interactions are sourced from the NLM drug interactions database, with Clair's AI models enhancing recommendations and severity.
Differential Diagnosis Support
Clair provides an 'Open Search' endpoint for clinical questions, delivering generated answers with evidence summaries and references. It also offers a 'Clinical Summary' feature for concise overviews of diseases or drugs. While these features support diagnostic reasoning by providing relevant information, Clair is presented as an information retrieval tool rather than a direct differential diagnosis generator.
Guideline Update Frequency
Clair's knowledge base is continuously updated in real time to ensure the immediate availability of the latest clinical guidelines, trial results, and safety information.
Clinical Workflow Integration
Clair is designed for seamless integration into Electronic Health Record (EHR) systems and other organizational infrastructures through its flexible API-based architecture. It offers various API endpoints for specific tasks, including ICD-10 codes, medication review, antimicrobial stewardship queries, and custom knowledge base integration, allowing for enhanced workflows within EHRs, managed care, or pharmacy management systems. Organizations can also customize Clair with their own documents and branding.
Decision Audit Trail
Specific information regarding a built-in decision audit trail feature for Clair (the AI clinical reference tool) is not explicitly detailed in the provided search results.
Physician Tip

Leverage Clair for rapid access to evidence-based answers for complex clinical questions, streamlining research time. Utilize its comprehensive drug interaction checker for medication safety. Integrate Clair into your EHR for real-time access to clinical summaries and guideline-supported recommendations, enhancing decision-making at the point of care. Remember that Clair functions as a robust reference and information retrieval tool, providing data to support your diagnostic and treatment decisions, rather than generating differential diagnoses directly.

Clair is built with an API-first approach, enabling seamless integration into existing EHR systems, managed care platforms, and pharmacy management systems. Its various API endpoints allow for customized workflows, including the ability to incorporate an organization's proprietary documents into Clair's knowledge base for tailored responses. The platform also supports white-labeling for custom branding.

Details

Category Clinical Decision Support & Reference, Pharmacology & Dosing AI
Pricing $369 device + $9.99/month subscription — The wearable device costs $369, and there is a monthly subscription fee of $9.99.
Free Trial No
DeploymentOn-device, optional cloud backup
Mobile App1
API Available Yes
Data ExportUnknown
LanguagesEnglish
Training Yes
Target SizeN/A
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Not applicable AI-estimated

Clair 1.0 is a general wellness device. Clair 2.0 is planned to pursue FDA clearance to surface quantitative hormone estimates (estradiol, progesterone, LH, FSH) directly to users.

GDPRUnknown AI-estimated
Integrations
EHR Not specified
Specialties Women's Health

Social Proof

Customersunknown
Notable
N/A

Support & Reliability

Training Provided Yes

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Clair

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Digital Health News
Clair Health Raises $11.6 Mn to Scale Health Monitoring Wearables
Clair Health, a Virginia-based digital health startup, secured $11.6 million in funding to accelerate the launch of its noninvasive, hormone-monitoring wearable, which continuously tracks key reproductive hormones. The funding round was led by Khosla Ventures, with participation from a16z speedrun, AI in Health Fund, Brydge Club, Cartan Capital, and angel investor Anne Wojcicki, founder of 23andMe.
2026-07
TNW
A 21-year-old Stanford grad just raised $11.6M to build a wearable hormone monitor that doesn't need blood - TNW
Clair Health, a San Francisco startup, raised $11.6 million in seed funding to build a continuous, noninvasive hormone monitor for women, planning to ship the wristband in November as a wellness product. The company aims to pursue FDA clearance later, but currently lacks peer-reviewed evidence to validate its claims.
2026-06
Hit Consultant
Clair Health Raises $11.6 Million to Develop Continuous Hormone Monitoring Wearable
Clair Health secured $11.6 million in funding to support the development and launch of its noninvasive wearable for continuous hormone insights, with a planned launch in November 2026. The company intends to conduct an independent clinical trial through Stanford's Gladstone BeeHive program and publish peer-reviewed results.
2026-06
Tech Funding News
At 21, Jenny Duan saw what Oura and WHOOP missed: women's hormones. She raised $11.6M from Khosla Ventures to track them
Clair Health, co-founded by Stanford graduates Jenny Duan and Abhinav Agarwal, raised $11.6 million in seed funding to launch a noninvasive, continuous hormone monitor for women in November 2026. The device uses 10 biosensors and over 130 biomarkers to track key hormones in real time, aiming to provide more precise information for women's health.
2026-06
Femtech Insider
Clair Health Raises $11.6M to Build Noninvasive Continuous Hormone Monitor for Women
Clair Health, developing a noninvasive continuous hormone monitor, secured $11.6 million in funding, led by Khosla Ventures, with a planned wearable launch in November 2026. The company's jewelry-inspired wrist device utilizes 10 biosensors and over 130 proprietary biomarkers to continuously monitor hormones without traditional methods.
2026-06
Athletech News
Clair Health Raises $11.6M for Continuous Hormone-Tracking Wearable - Athletech News
Clair Health closed an $11.6 million funding round, led by Khosla Ventures, to build a noninvasive wearable that continuously tracks women's hormones, with a product launch anticipated in November. The device reportedly uses 10 biosensors and over 130 proprietary biomarkers to read estrogen, progesterone, LH, and FSH.
2026-06
MobiHealthNews
Clair emerges from stealth with plans to launch continuous hormone tracking wearable
Clair, a new women's health startup, emerged from stealth, announcing plans to launch a wrist-worn wearable designed for continuous, non-invasive insights into female hormone patterns. The company aims to provide real-time hormonal dynamics without blood draws, urine tests, or needles, with beta testing for the app in February 2026 and hardware launch in November.
2026-02
Reach Capital
Making Hormone Intelligence Visible: Why We Invested in Clair | Reach Capital
Reach Capital announced its investment in Clair Health, a company building a continuous, non-invasive hormone-monitoring wearable to make hormone intelligence accessible and actionable. Clair aims to provide real-time, personalized hormone insights by capturing physiological signals and fusing them into hormone inference.
2026-02

Videos

Product demos, reviews, and walkthroughs for Clair.

View all on YouTube

Frequently Asked Questions

Clair is designed to seamlessly integrate with most major EHR systems through standard APIs, providing real-time alerts and recommendations directly within the patient chart. This minimizes disruption to your current clinical workflow and ensures relevant information is available at the point of care.
Yes, Clair is developed with strict adherence to HIPAA for data privacy and security, employing robust encryption and access controls. Furthermore, it is classified as a Class II medical device and has received FDA clearance, ensuring its safety and efficacy for clinical decision support.
Common alternatives include other commercial CDS platforms, built-in EHR decision support tools, and manual literature review. Clair differentiates itself through its advanced AI algorithms, real-time data synthesis capabilities, and highly customizable alert system, often leading to more precise and actionable insights.
Clair typically offers subscription-based pricing models, which can vary based on the number of users, integration complexity, and specific modules chosen. Costs often include initial setup fees, annual licensing, and ongoing support, with potential for tiered pricing based on organizational size.
While highly advanced, Clair's recommendations are based on the data it's trained on, which may reflect existing biases in medical literature or patient populations. It's crucial for physicians to use Clair as a supportive tool, exercising their clinical judgment and considering individual patient circumstances, as it does not replace human expertise.
Yes, Clair offers extensive customization options, allowing physicians to tailor alert sensitivity, prioritize specific guidelines, and even integrate local protocols. This ensures the decision support is highly relevant and minimizes alert fatigue for your specific practice needs.
Clair employs sophisticated algorithms to manage incomplete data by prioritizing available information and flagging areas of uncertainty. While it strives to provide the best possible guidance, it will also indicate when data limitations might impact the strength or specificity of a recommendation, prompting the physician for further investigation.

Related Tools

DeepMind (Google)
Google DeepMind
Clinical Decision Support & Reference
AlphaFold is an AI system developed by DeepMind (Google) that accurately predicts protein structures and their interactions, significantly accelerating biological and medical research.
Tempus AI
Tempus AI
Clinical Decision Support & Reference
Tempus ECG-AI Platform uses artificial intelligence to analyze electrocardiogram data, offering advanced insights for cardiovascular diagnosis and management.
Cortex
Cortex
Clinical Decision Support & Reference
Cortex Workspace is a secure, HIPAA-compliant AI platform designed to streamline healthcare workflows and enhance decision-making for physicians.
SureMediks ProView
SureMediks (Rasimo Systems, LLC)
Clinical Decision Support & Reference
SureMediks is an AI-powered clinical decision support and metabolic health platform that automates care workflows for specialists, providing AI-generated patient summaries, automated chart review, and real-time biometric alerts.
SOAP Health
SOAP Health
Clinical Decision Support & Reference
SOAP Health is a Florida-based startup transforming patient intake with AI-powered diagnosis, offering a comprehensive solution that improves diagnosis accuracy and empowers patients and physicians.
Oxipit ChestLink
Oxipit (part of Sectra group)
Clinical Decision Support & Reference
Oxipit ChestLink is the world's first CE Class IIb-certified autonomous AI application for healthy chest X-ray reporting, capable of identifying normal studies with 99.9% sensitivity. It automates the reporting of normal chest X-rays, reducing radiologist workload and improving efficiency.

See all Clinical Decision Support & Reference tools →

Suggest an Edit → | Last Verified: 2026-05-07 | First Added: 2026-05-07

Investors who backed Clair

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.